Barr, Kos Pharma In Talks To Settle Niaspan Patent Litigation

Law360, New York (March 30, 2005, 12:00 AM EST) -- Barr Pharmaceuticals Inc. and Kos Pharmaceuticals Inc. are in talks to settle their outstanding patent litigation regarding Kos' cholesterol reducing drug Niaspan, the two companies said Wednesday.

The case is currently before the U.S. District Court for the Southern District of New York. A trial is tentatively scheduled to begin in February 2006.

The companies said they expect the court to discontinue and stay all proceedings to allow the parties to negotiate a definitive settlement agreement.

The companies will have the right to have the matter...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.